on AFYREN (EPA:ALAFY)
AFYREN NEOXY Achieves First Significant Revenue in 2025
In 2025, AFYREN NEOXY, a greentech company, achieved its first significant revenue through the production of bio-based acids. Approximately 400 tons were produced, resulting in total sales of about €1 million, with €0.5 million already invoiced. This marks an important milestone despite revenues being below initial forecasts.
The company faced some challenges due to voluntary shutdowns aimed at improving operations, which temporarily limited production capacity between July and October. In the final months of 2025, production surged, contributing nearly half of the year's total volume.
AFYREN secured sales for all produced volumes, delivering to nine customers, including five from existing contracts. The company also won a competitive tender for 2026, reflecting potential growth in its market segments.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AFYREN news